Company Directory > Biotech > Houston Methodist
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Houston Methodist and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Houston Methodist is a leading nonprofit academic medical center based in the Texas Medical Center, Houston. It operates eight hospitals and a comprehensive research institute dedicated to translating laboratory discoveries into novel clinical treatments and cures. The organization is renowned for its interdisciplinary approach to medicine, integrating advanced research, technology development, and patient care. The institution maintains a robust research infrastructure, including cGMP-compliant manufacturing facilities for therapeutics and devices, and supports a wide range of clinical trials. It focuses on translational medicine across various fields, including oncology, neurosciences, cardiovascular science, and nanomedicine, aiming to bridge the gap between bench-side innovation and bedside application.
CLASSIFICATION
Company Type:Biotech
Industry:Medical Devices
Sub-Industry:Academic Medical Center / Translational Research
SIZE & FINANCIALS
Employees:10000+
Founded:1919
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Phase 1/2
Modalities:Small molecule, mRNA, Nanomaterials, Cell therapy, Gene therapy
Active Trials:760
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Weill Cornell Medical School (Academic affiliation), Rice University (Research collaboration), Texas A&M University (EnMed program)
COMPETITION
Position:Leader
Competitors:UPMC, Inova, Northwell Health
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Houston Methodist. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.